4//SEC Filing
Eiger BioPharmaceuticals, Inc. 4
Accession 0001209191-16-111822
CIK 0001305253operating
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 7:03 PM ET
Size
8.7 KB
Accession
0001209191-16-111822
Insider Transaction Report
Form 4
Bramlage Charles
Director
Transactions
- Award
Stock Option (Right to Buy)
2016-03-28+25,000→ 25,000 totalExercise: $15.75Exp: 2026-03-28→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The option vests in equal monthly installments over 12 months measured from March 28, 2016 subject to Reporting Person's continuous service status as of each such date.
- [F2]The option is subject to shareholder approval of an amendment to the Celladon Corporation 2013 Equity Incentive Plan. This is a voluntary early filing.
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeoperating
Related Parties
1- filerCIK 0001305253
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 7:03 PM ET
- Size
- 8.7 KB